Elagawany M, Abdel Ghany L, Ibrahim T, Alharbi A, Abdel-Aziz M, El-Labbad E
J Enzyme Inhib Med Chem. 2024; 39(1):2311157.
PMID: 38348846
PMC: 10866054.
DOI: 10.1080/14756366.2024.2311157.
Singh A, Singh K, Sharma A, Sharma S, Batra K, Joshi K
Mol Cell Biochem. 2023; 479(5):1165-1198.
PMID: 37329491
DOI: 10.1007/s11010-023-04786-0.
Al-Warhi T, Almahli H, Maklad R, Elsayed Z, El Hassab M, Alotaibi O
Molecules. 2023; 28(7).
PMID: 37049966
PMC: 10096524.
DOI: 10.3390/molecules28073203.
Khalil A, El-Moselhy T, El-Bastawissy E, Abdelhady R, Younis N, El-Hamamsy M
J Enzyme Inhib Med Chem. 2023; 38(1):2157411.
PMID: 36629449
PMC: 9848300.
DOI: 10.1080/14756366.2022.2157411.
Tawfik H, Belal A, Abourehab M, Angeli A, Bonardi A, Supuran C
J Enzyme Inhib Med Chem. 2022; 37(1):2765-2785.
PMID: 36210545
PMC: 9559471.
DOI: 10.1080/14756366.2022.2130285.
Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX.
Zain-Alabdeen A, El-Moselhy T, Sharafeldin N, Angeli A, Supuran C, El-Hamamsy M
Sci Rep. 2022; 12(1):16756.
PMID: 36202955
PMC: 9537541.
DOI: 10.1038/s41598-022-21024-7.
In Silico Pharmacokinetic Profiling of the Identified Bioactive Metabolites of L. Latex Extract and In Vitro Cytotoxic Activity via the Induction of Caspase-Dependent Apoptosis with S-Phase Arrest.
Abouzied A, Abd-Rabo M, Huwaimel B, Almahmoud S, Almarshdi A, Alharbi F
Pharmaceuticals (Basel). 2022; 15(9).
PMID: 36145353
PMC: 9501251.
DOI: 10.3390/ph15091132.
Discovery of new symmetrical and asymmetrical nitrile-containing 1,4-dihydropyridine derivatives as dual kinases and P-glycoprotein inhibitors: synthesis, assays, and studies.
Saad M, El-Moselhy T, S El-Din N, Mehany A, Belal A, Abourehab M
J Enzyme Inhib Med Chem. 2022; 37(1):2489-2511.
PMID: 36093880
PMC: 9481151.
DOI: 10.1080/14756366.2022.2120478.
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, studies, and antiproliferative evaluation.
Taghour M, Mahdy H, Gomaa M, Aglan A, Eldeib M, Elwan A
J Enzyme Inhib Med Chem. 2022; 37(1):2063-2077.
PMID: 35875937
PMC: 9327782.
DOI: 10.1080/14756366.2022.2103552.
Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).
Dhiman A, Sharma R, Singh R
Acta Pharm Sin B. 2022; 12(7):3006-3027.
PMID: 35865090
PMC: 9293743.
DOI: 10.1016/j.apsb.2022.03.021.
Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules.
Elkaeed E, Abd El Salam H, Sabt A, Al-Ansary G, Eldehna W
Molecules. 2021; 26(24).
PMID: 34946704
PMC: 8709016.
DOI: 10.3390/molecules26247611.
Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency.
de Paiva R, Vieira E, Rodrigues da Silva D, Anchau Wegermann C, Costa Ferreira A
Front Mol Biosci. 2021; 7:627272.
PMID: 33614708
PMC: 7889591.
DOI: 10.3389/fmolb.2020.627272.
Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and studies.
Eldehna W, Al-Rashood S, Al-Warhi T, Eskandrani R, Alharbi A, El Kerdawy A
J Enzyme Inhib Med Chem. 2020; 36(1):270-285.
PMID: 33327806
PMC: 7751407.
DOI: 10.1080/14756366.2020.1862101.
Dual Targeting of VEGFR2 and C-Met Kinases via the Design and Synthesis of Substituted 3-(Triazolo-thiadiazin-3-yl)indolin-2-one Derivatives as Angiogenesis Inhibitors.
Mohamady S, Galal M, Eldehna W, Gutierrez D, Ibrahim H, Elmazar M
ACS Omega. 2020; 5(30):18872-18886.
PMID: 32775889
PMC: 7408256.
DOI: 10.1021/acsomega.0c02038.
Novel [(-alkyl-3-indolylmethylene)hydrazono]oxindoles arrest cell cycle and induce cell apoptosis by inhibiting CDK2 and Bcl-2: synthesis, biological evaluation and studies.
Al-Warhi T, Abo-Ashour M, Almahli H, Alotaibi O, Al-Sanea M, Al-Ansary G
J Enzyme Inhib Med Chem. 2020; 35(1):1300-1309.
PMID: 32522063
PMC: 7717600.
DOI: 10.1080/14756366.2020.1773814.
Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
Al-Warhi T, El Kerdawy A, Aljaeed N, Ismael O, Ayyad R, Eldehna W
Molecules. 2020; 25(9).
PMID: 32349307
PMC: 7248897.
DOI: 10.3390/molecules25092031.
Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity.
Al-Rashood S, Hamed A, Hassan G, Alkahtani H, Almehizia A, Alharbi A
J Enzyme Inhib Med Chem. 2020; 35(1):831-839.
PMID: 32208781
PMC: 7144320.
DOI: 10.1080/14756366.2020.1743281.
Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety.
Al-Sanea M, Gotina L, Mohamed M, Parambi D, Gomaa H, Mathew B
Drug Des Devel Ther. 2020; 14:497-508.
PMID: 32103894
PMC: 7008064.
DOI: 10.2147/DDDT.S237957.
Antiproliferative activity and possible mechanism of action of certain 5-methoxyindole tethered C-5 functionalized isatins.
Almutairi M, Hassan E, Keeton A, Piazza G, Abdelhameed A, Attia M
Drug Des Devel Ther. 2019; 13:3069-3078.
PMID: 31695325
PMC: 6718129.
DOI: 10.2147/DDDT.S208241.
Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights.
Abdelrahman M, Eldehna W, Nocentini A, Bua S, Al-Rashood S, Hassan G
Int J Mol Sci. 2019; 20(10).
PMID: 31137489
PMC: 6566410.
DOI: 10.3390/ijms20102484.